C4 THERAPEUTICS INC (CCCC) Stock Earnings & Estimates
USA - NASDAQ:CCCC - US12529R1077 - Common Stock
2.22 USD
+0.2 (+9.9%)
2.18 USD
-0.04 (-1.8%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 31.1M -32.08% | 20.756M -33.26% | 35.584M 71.44% | 27.519M -22.66% | 21.814M -20.73% | 21.694M -0.55% | 138.6M 538.89% | 1.274B 819.19% | 3.609B 183.28% | 277.82M -92.30% | 407.5M 46.68% | |
| EBITDA YoY % growth | -127.85M -58.54% | -137.151M -7.27% | -115.359M 15.89% | -113.225M 1.85% | -133.592M -17.99% | -144.462M -8.14% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -129.53M -57.71% | -139.031M -7.33% | -117.177M 15.72% | -121.292M -3.51% | -150.928M -24.43% | -150.762M 0.11% | -72.006M 52.24% | 282.43M 492.23% | 1.179B 317.45% | 37.841M -96.79% | 155.93M 312.07% | |
| Operating Margin | -416.50% | -669.84% | -329.30% | -440.76% | -691.88% | -694.95% | -51.95% | 22.17% | 32.67% | 13.62% | 38.27% | |
| EPS YoY % growth | -2.63 -44.51% | -2.66 -1.14% | -1.51 43.23% | -1.64 -8.30% | -1.87 -14.49% | -1.42 24.10% | -0.53 62.86% | 4.78 1,006.28% | 18.06 277.61% | 0.47 -97.40% | 1.43 205.80% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.41 -18.36% | -0.40 19.38% | -0.44 -18.54% | -0.44 -18.54% |
| Revenue Q2Q % growth | 6.406M -58.30% | 6.61M 27.68% | 2.55M -64.77% | 2.55M -60.54% |
| EBITDA Q2Q % growth | -38.76M -44.06% | -36.261M -1.03% | N/A | N/A |
| EBIT Q2Q % growth | -31.181M -10.40% | -33.25M 11.82% | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.37 -42.31% | -0.39 | 0.02 | 5.54% |
| Q1 2025 Q2Q % growth | -0.37 9.76% | -0.46 | 0.09 | 19.39% |
| Q4 2024 Q2Q % growth | -0.49 30.00% | -0.49 | 0.00 | -0.55% |
| Q3 2024 Q2Q % growth | -0.35 32.69% | -0.39 | 0.04 | 9.70% |
| Q2 2024 Q2Q % growth | -0.26 64.38% | -0.38 | 0.12 | 31.42% |
| Q1 2024 Q2Q % growth | -0.41 42.25% | -0.36 | -0.05 | -14.38% |
| Q4 2023 Q2Q % growth | -0.70 9.09% | -0.70 | 0.00 | -0.55% |
| Q3 2023 Q2Q % growth | -0.52 20.00% | -0.67 | 0.15 | 22.76% |
| Q2 2023 Q2Q % growth | -0.73 -30.36% | -0.70 | -0.03 | -4.06% |
| Q1 2023 Q2Q % growth | -0.71 -9.23% | -0.76 | 0.05 | 6.66% |
| Q4 2022 Q2Q % growth | -0.77 -148.39% | -0.76 | -0.01 | -1.50% |
| Q3 2022 Q2Q % growth | -0.65 -27.45% | -0.68 | 0.03 | 4.89% |
| Q2 2022 Q2Q % growth | -0.56 -9.80% | -0.71 | 0.15 | 20.76% |
| Q1 2022 Q2Q % growth | -0.65 -32.65% | -0.59 | -0.06 | -10.14% |
| Q4 2021 Q2Q % growth | -0.31 -675.00% | -0.59 | 0.28 | 47.82% |
| Q3 2021 Q2Q % growth | -0.51 97.09% | -0.60 | 0.09 | 15.49% |
| Q2 2021 Q2Q % growth | -0.51 | -0.60 | 0.09 | 15.25% |
| Q1 2021 Q2Q % growth | -0.49 | -0.64 | 0.15 | 23.75% |
| Q4 2020 Q2Q % growth | -0.04 | -0.54 | 0.50 | 92.60% |
| Q3 2020 Q2Q % growth | -17.55 | -0.81 | -16.74 | -2,077.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 6.463M -46.17% | 6.681M | -218K | -3.26% |
| Q1 2025 Q2Q % growth | 7.238M 138.17% | 4.539M | 2.699M | 59.46% |
| Q4 2024 Q2Q % growth | 5.177M 58.75% | 5.228M | -51K | -0.98% |
| Q3 2024 Q2Q % growth | 15.362M 38.75% | 4.692M | 10.67M | 227.41% |
| Q2 2024 Q2Q % growth | 12.006M 350.68% | 4.879M | 7.127M | 146.08% |
| Q1 2024 Q2Q % growth | 3.039M -19.15% | 8.262M | -5.223M | -63.22% |
| Q4 2023 Q2Q % growth | 3.261M 14.42% | 3.253M | 8K | 0.25% |
| Q3 2023 Q2Q % growth | 11.072M 64.03% | 5.569M | 5.503M | 98.81% |
| Q2 2023 Q2Q % growth | 2.664M -80.74% | 6.568M | -3.904M | -59.44% |
| Q1 2023 Q2Q % growth | 3.759M -50.86% | 5.572M | -1.813M | -32.54% |
| Q4 2022 Q2Q % growth | 2.85M -85.81% | 7.969M | -5.119M | -64.24% |
| Q3 2022 Q2Q % growth | 6.75M -20.59% | 9.253M | -2.503M | -27.05% |
| Q2 2022 Q2Q % growth | 13.83M 41.41% | 7.79M | 6.04M | 77.54% |
| Q1 2022 Q2Q % growth | 7.65M 2.96% | 8.211M | -561K | -6.83% |
| Q4 2021 Q2Q % growth | 20.08M 143.10% | 7.226M | 12.854M | 177.89% |
| Q3 2021 Q2Q % growth | 8.5M 0.59% | 7.759M | 741K | 9.55% |
| Q2 2021 Q2Q % growth | 9.78M -40.68% | 6.137M | 3.643M | 59.36% |
| Q1 2021 Q2Q % growth | 7.43M | 3.942M | 3.488M | 88.48% |
| Q4 2020 Q2Q % growth | 8.26M -61.37% | 8.16M | 100K | 1.23% |
| Q3 2020 Q2Q % growth | 8.45M | 5.202M | 3.248M | 62.44% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.11% | 9.34% | -2.94% | 7.85% |
| Revenue | 0% | -7.64% | 5.9% | 6.23% |